Stock A003090 DAEWOONG CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Daewoong Co., Ltd.

Equities

A003090

KR7003090008

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 29/04/2024 BST 		5-day change 1st Jan Change
18,820 KRW +0.64% Intraday chart for Daewoong Co., Ltd. +3.75% -8.86%
04-24 Korean Sugar Imports Plunge 14% as Diabetes Cases Surge MT
03-08 Daewoong Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Korean Sugar Imports Plunge 14% as Diabetes Cases Surge
MT
Daewoong Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Daewoong Pharmaceutical Secures Approval for Stem Cell Processing Facility in Indonesia
MT
Tranche Update on Daewoong Co., Ltd.'s Equity Buyback Plan announced on July 27, 2023.
CI
Tranche Update on Daewoong Co., Ltd.'s Equity Buyback Plan announced on July 27, 2023.
CI
Daewoong Co., Ltd.'s Equity Buyback announced on July 27, 2023, has closed with 690,630 shares, representing 1.66% for KRW 9,997.24 million.
CI
Zydus Unit, Daewoong Pharma to Co-Develop, Commercialize Leuprolide Acetate in US
MT
Daewoong Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Tranche Update on Daewoong Co., Ltd.'s Equity Buyback Plan announced on July 27, 2023.
CI
Hyphens Pharma Unit to Distribute Daewoong Pharmaceutical's Nabota Botox in Malaysia
MT
Daewoong Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Daewoong Pharmaceutical's Nabota Surpasses 600,000 Customers in the US
MT
Daewoong Co., Ltd. announces an Equity Buyback for KRW 10,000 million worth of its shares.
CI
Daewoong Co., Ltd. authorizes a Buyback Plan.
CI
Avacta sees shares rise on new equity payment for South Korea venture
AN
Daewoong Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Daewoong Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
An Unknown buyer completed the acquisition of 66.2% stake in Palmpack Co., Ltd. from Daewoong Co., Ltd..
CI
Sonoma Pharmaceuticals Signs Distribution Deal With Daewoong Pharmaceutical to Sell Skin Products in South Korea
MT
Oncorus, Daewoong Pharmaceutical to Develop Lipid Nanoparticle Formulations for mRNA Drug Candidate; Shares Surge
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A003090 Stock
  4. News Daewoong Co., Ltd.